The developing practice of combining kratom, a permitted botanical, with pain reliever – often referred to as "Kratom Lean" – presents a challenging legal lacuna. For now, the countrywide regulated status of kratom is in flux, varying considerably by state among localities, while codeine’s restricted nature adds another aspect of legal doubt.

The alarming popularity of "legal lean" syrup, a concoction with codeine and copyright, is creating a particularly risky situation when mixed with kratom. These act on the central nervous system in separate ways, but their concurrent effects can be severe. Users may experience heightened respiratory slowdown, increased sedation, and a higher risk o